Cargando…
Two contrasting papers stimulate a commentary on the origins of tumour immunology, current cancer immunotherapies, and the future potential for cancer immunotherapy
Two early papers expressing conflicting views on the occurrence of effective immune attack against cancers stimulate an analysis of the gradual development of an understanding of tumour biology. This understanding has led to the development of the strikingly effective check point blocking and CART a...
Autor principal: | Bodmer, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938177/ https://www.ncbi.nlm.nih.gov/pubmed/36476657 http://dx.doi.org/10.1038/s41416-022-02075-z |
Ejemplares similares
-
Precision intervention of cell type-specific targeting is required for future cancer immunotherapy
por: Cai, Yitong, et al.
Publicado: (2023) -
Bioengineering of bacteria for cancer immunotherapy
por: Nguyen, Dinh-Huy, et al.
Publicado: (2023) -
Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
por: Błach, Justyna, et al.
Publicado: (2021) -
T-cell tumour exclusion and immunotherapy resistance: a role for CAF targeting
por: Hanley, Christopher J., et al.
Publicado: (2020) -
Cancer immunotherapy comes of age and looks for maturity
por: Finck, Amanda, et al.
Publicado: (2020)